Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in

Hiromi Shimada1, Risa Wakiya1, Tomohiro Kameda1

  • 1Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.

Lupus
|May 16, 2023
PubMed

Insights

Disease activity in systemic lupus erythematosus (SLE) significantly impacts pregnancy outcomes. Monitoring complement levels and anti-dsDNA antibody titers can help predict and manage preterm birth and low birth weight risks.

Area of Science:

  • Rheumatology
  • Obstetrics
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) poses significant risks during pregnancy.
  • Preterm birth (PB) and low birth weight (LBW) are known complications in SLE pregnancies.
  • Identifying specific disease activity markers associated with adverse pregnancy outcomes is crucial.

Purpose of the Study:

  • To identify disease activity parameters that are risk factors for PB and LBW in SLE patients.
  • To analyze the extent of the impact of these parameters on PB and LBW.

Main Methods:

  • Retrospective analysis of 60 pregnancies in SLE patients.
  • Collection of disease activity parameters: SLE Disease Activity Index (SLEDAI), lupus low disease activity state (LLDAS) attainment, complement levels (C3, CH50), and anti-double stranded DNA (anti-dsDNA) antibody titers.
  • Association analysis of these parameters with PB and LBW.

Main Results:

  • C3 levels and anti-dsDNA antibody titers at conception were associated with PB (p=0.03, p=0.01).
  • C3 and CH50 levels were associated with LBW (p=0.02, p=0.03).
  • Logistic regression identified cutoff values for C3, anti-dsDNA, and CH50, with combined cutoffs significantly increasing PB and LBW risk.

Conclusions:

  • PB and LBW are strongly linked to specific disease activity parameters in SLE pregnancies.
  • Close monitoring and control of SLE disease activity markers, even without overt clinical symptoms, are vital for improving pregnancy outcomes.
  • Proactive management of SLE disease activity can mitigate risks of PB and LBW.
Abstract